IonPath
4 known investors
Find your way into IonPath
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BSep 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does IonPath do?
- IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
- Who are IonPath's investors?
- IonPath's investors include Hemisphere Ventures LLC, Norwich Ventures, Vertical Venture Partners, Samsara BioCapital.